SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-014001
Filing Date
2021-11-02
Accepted
2021-11-02 08:21:04
Documents
69
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcel-20210930x10q.htm   iXBRL 10-Q 2213074
2 EX-31.1 bcel-20210930xex31d1.htm EX-31.1 12733
3 EX-31.2 bcel-20210930xex31d2.htm EX-31.2 12317
4 EX-32.1 bcel-20210930xex32d1.htm EX-32.1 8157
  Complete submission text file 0001558370-21-014001.txt   7474419

Data Files

Seq Description Document Type Size
5 EX-101.SCH bcel-20210930.xsd EX-101.SCH 41701
6 EX-101.CAL bcel-20210930_cal.xml EX-101.CAL 52027
7 EX-101.DEF bcel-20210930_def.xml EX-101.DEF 199074
8 EX-101.LAB bcel-20210930_lab.xml EX-101.LAB 357173
9 EX-101.PRE bcel-20210930_pre.xml EX-101.PRE 315015
10 EXTRACTED XBRL INSTANCE DOCUMENT bcel-20210930x10q_htm.xml XML 1324525
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38935 | Film No.: 211369369
SIC: 2834 Pharmaceutical Preparations